McKesson to pay $151M to states to settle inflated price charges
This article was originally published in Scrip
Executive Summary
US drug distributor giant McKesson has agreed to pay $151 million to settle charges of inflating prices of over 1,400 brand-name prescription medications, including Pfizer's Lipitor (atorvastatin) and Forest's Celexa (citalopram), causing 29 states' Medicaid programs to overpay for the drugs.